Opportunity
Federal Register #2026-20770
NIH Center for Scientific Review Closed Grant-Review Meetings
Buyer
Department of Health and Human Services — National Institutes of Health
Posted
October 09, 2026
Identifier
2026-20770
The National Institutes of Health’s Center for Scientific Review is announcing closed meetings to evaluate grant applications across biomedical and health research fields. - Government organizations: U.S. Department of Health and Human Services (HHS), National Institutes of Health (NIH), and NIH Center for Scientific Review (CSR). A separately announced meeting involves the National Institute of Allergy and Infectious Diseases (NIAID) Division of Intramural Research Board of Scientific Counselors. - Meeting purpose and topics: Scientific panels will review grant applications covering cardiovascular and respiratory sciences; National Primate Research Centers; neuromodulation and neuronal-circuit imaging; reproductive health; musculoskeletal and oral sciences; health implementation and delivery; health services and systems; neurovascular and blood-brain barrier research; biological chemistry and biophysics; cellular, developmental, and bioengineering sciences; substance-use-disorder pharmacotherapies; neuroscience training and career development; and population health and epidemiology. - Format and access: Meetings are generally virtual; the separately announced NIAID board meeting is in person. Meetings are closed to the public because discussions may involve confidential commercial information and personal information. - Procurement scope: This is an advisory-meeting notice, not a solicitation for products or services. No OEMs, vendors, product quantities, or part numbers are identified.
Description
The notice announces closed meetings of the National Institutes of Health's Center for Scientific Review. The meetings will review and evaluate grant applications, with the notice listing multiple panels, dates, times, and meeting formats. They are closed to the public because discussions may disclose confidential commercial information and personal information. The listed meetings begin November 4, 2026.